Clinical Trial of Vildagliptin in Early Parkinson's Disease

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Parkinson's Disease

Interventions

DRUG

Vildagliptin 50 mg bid

Vildagliptin 50 mg bid for 12months

All Listed Sponsors

lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT06951334 - Clinical Trial of Vildagliptin in Early Parkinson's Disease | Biotech Hunter | Biotech Hunter